A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees

J CROWEJR, P BUI, A DAVIS, R CHANOCK, B MURPHY
  • Vaccine, January 1994, Elsevier
  • DOI: 10.1016/0264-410x(94)90286-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/0264-410x(94)90286-0

The following have contributed to this page: Dr James E Crowe